NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News $7.67 +0.10 (+1.32%) Closing price 06/20/2025 04:10 PM EasternExtended Trading$7.64 -0.04 (-0.46%) As of 06/20/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipShort InterestBuy This Stock About Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LABD alerts:Sign Up Key Stats Today's Range$7.41▼$7.8550-Day Range$6.88▼$10.7152-Week Range$4.78▼$16.05Volume10.73 million shsAverage Volume16.26 million shsMarket Capitalization$61.90 millionAssets Under Management$52.50 millionDividend Yield4.30%Net Expense Ratio1.07%Aggregate RatingN/A ETF OverviewThe Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.Read More… Direxion Daily S&P Biotech Bear 3x Shares ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.56%0.51%0.53%Other Expenses0.33%0.47%0.57%0.60%0.56%Total Expense1.08%0.75%0.76%0.74%0.73%Fee Waiver-0.01%-0.67%-0.67%-0.72%-0.63%Net Expense1.07%0.60%0.63%0.58%0.60% Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address LABD ETF News HeadlinesTSLL, LABD: Big ETF OutflowsMay 13, 2025 | nasdaq.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.1264December 24, 2024 | msn.comA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the key to unlocking technological breakthroughs we once thought were impossible. And it may just be the only thing capable of bringing America back from the brink of recession – despite Washington’s incompetence and addiction to reckless spending. That’s why Elon Musk, Jeff Bezos, Jensen Huang, and even Bill Gates are pouring billions into the infrastructure behind it.June 22, 2025 | Porter & Company (Ad)Direxion Daily S&P Biotech Bear 3X Shares (LABD) Dividend HistoryDecember 23, 2024 | nasdaq.comDirexion Daily S&P 500 Bear 3X (ARCA:SPXS), Short Interest ReportOctober 15, 2024 | benzinga.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0890September 24, 2024 | msn.comSee More Headlines LABD ETF - Frequently Asked Questions How have LABD shares performed this year? Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $7.25 at the start of the year. Since then, LABD shares have increased by 5.8% and is now trading at $7.67. View the best growth stocks for 2025 here. When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? Shares of Direxion Daily S&P Biotech Bear 3x Shares reverse split on the morning of Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders? Direxion Daily S&P Biotech Bear 3x Shares' top institutional shareholders include Virtu Financial LLC (19.09%), Jump Financial LLC (1.51%) and Headlands Technologies LLC (0.79%). How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3x Shares investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3x Shares (LABU), NVIDIA (NVDA) and Intel (INTC). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings16 Fund Statistics Assets Under Management$52.50 million Average Daily Volume$12.06 million Discount/Premium0.02% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume1,427 Put Options835 Call Options592 Short Interest1,890,000 shs Miscellaneous Outstanding Shares8,070,000Beta-2.45 Creation Unit50,000 Creation Fee$250.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Top 9 LABD HoldingsDreyfus Govt Cash Man InsHolding Weight: 52.36%Goldman Sachs Sterling FixInc Port IncHolding Weight: 44.08%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 18.22%Dreyfus Trsry Securities Cash MgmtHolding Weight: 12.85%CashHolding Weight: -2.83%Citi CollateralHolding Weight: -2.99%Baml CollateralHolding Weight: -3.89%Goldman CollateralHolding Weight: -7.43%S&P Biotechnology Select Industry Index SwapHolding Weight: -10.38%Full Holdings Details This page (NYSEARCA:LABD) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersWhy hasn't Elon tweeted about this?Behind the scenes, there's an entirely different Tesla story brewing… . It's about a quiet stream of income...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.